Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Second Genome Doses First Patient in SGM-1019 Study

americanpharmaceuticalreviewJanuary 24, 2019

Tag: NASH , Second Genome , SGM-1019 , small molecule inhibitor

PharmaSources Customer Service